News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The bioanalytical contract research organization (CRO) has named a new CEO, Jeff Goddard, who also will join the company’s board of directors.
“I’d like to continue building on the forward thinking vision of AIT Bioscience’s founders to become the bioanalytical partner of choice for biopharmaceutical and animal health companies as they discover and develop new therapies,” Goddard told us.
Goddard has worked for both start-ups to Fortune 500 firms, holding various positions at EPL Archives (acquired by VWR International in 2017), Biostorage Technologies (now Brooks Life Science), Gene Logic, and Nalco Chemical Company.